Pharmafile Logo
Pharmafocus logo
Advanced Search

merger

Showing 15 posts of 70 posts found.

ea_pharma

Eisai announces agreement to set up new gastrointestinal speciality company

March 30, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Ajinomoto, Eisai, absorption, acquisition, ea pharma, gastrointestinal, merger, speciality

Eisai (TYO: 4523) and Ajinomoto Co. (TYO: 2802) have announced an agreement to establish a new gastrointestinal speciality pharmaceutical company, …

News
asthma_inhalers

Vectura agree £441m merger with Skyepharma

March 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Skyepharma, UK, biotech, merger, vectura

Vectura (LON: VEC) and Skyepharma (LON: SKP), two UK-based pharma companies, have joined together in a deal worth £441m. The …

News
Logos

Reports: $32bn Shire takeover of Baxalta close to done deal

January 4, 2016
Sales and Marketing Baxalta, Shire, acquisition, merger

The deal may have failed to get over the line in 2015, but reports suggest the mega merger is to …

News
GSK image

GSK ploughs $95m into research institute

June 17, 2015
Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover

GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …

News

Analysts predict Pfizer to swallow GSK

May 21, 2015
Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger

GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …

News

Pharma M&A trail continues as Pfizer buys slice of Dutch biotech

May 12, 2015
Sales and Marketing Endo, Pfizer, aspen, merger

Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …

News
Perrigo image

Perrigo bats away raised Mylan bid

April 30, 2015
Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger

Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …

News
Teva image

Teva moves to buy Mylan

April 21, 2015
Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …

News
GSK image

GSK sees further US job losses following Novartis deal

April 17, 2015
Research and Development, Sales and Marketing GSK, Jobs, Novartis, cuts, merger, pittsburgh, restructuring

Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …

News
Takeda image

Takeda buys license to ImmunoGen cancer tech

March 24, 2015
Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …

News
GSK image

GSK sells off stake in Aspen for $853m

March 13, 2015
Sales and Marketing Africa, China, GSK, Novartis, Singapore, aspen, merger, redfern

GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …

News
Salix image

Endo attempts to outbid Valeant for Salix Pharma

March 12, 2015
Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix

Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …

News
GSK image

GSK and Novartis swap assets

March 1, 2015
Research and Development, Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, akt, merger, oncology, vaccines

GlaxoSmithKline’s planned major assets swap with Novartis has completed today as was predicted last week. Both firms announced the overhaul …

News
Sanofi image

Sanofi makes gene therapy move

February 13, 2015
Research and Development, Sales and Marketing Genzyme, Sanofi, Voyager Therapeutics, gene therapy, merger

Sanofi has signalled its intent to develop gene therapy treatments for nerve diseases through a $745 million deal with US …

News
Propofol image

Hospira recalls Propofol drug again

February 10, 2015
Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol

Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026